Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMC 2871496)

Published in J Biol Chem on March 11, 2010

Authors

Jason R Burke1, Alison J Deshong, Jeffrey G Pelton, Seth M Rubin

Author Affiliations

1: Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064, USA.

Articles citing this

Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol (2013) 2.58

Methylation of the retinoblastoma tumor suppressor by SMYD2. J Biol Chem (2010) 1.73

The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway. PLoS Biol (2013) 1.47

Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem Sci (2012) 1.46

Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev (2012) 1.37

RB1, development, and cancer. Curr Top Dev Biol (2011) 1.37

Newly identified aspects of tumor suppression by RB. Dis Model Mech (2011) 1.24

Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation. Mol Cell (2011) 1.21

An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat Struct Mol Biol (2010) 1.20

Conserved RB functions in development and tumor suppression. Protein Cell (2011) 1.15

A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression. Mol Cell (2013) 1.02

Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Cell Death Differ (2012) 0.99

Cks confers specificity to phosphorylation-dependent CDK signaling pathways. Nat Struct Mol Biol (2013) 0.99

Arterial territory-specific phosphorylated retinoblastoma protein species and CDK2 promote differences in the vascular smooth muscle cell response to mitogens. Cell Cycle (2013) 0.96

The CDK Network: Linking Cycles of Cell Division and Gene Expression. Genes Cancer (2012) 0.96

Crystal structure of the unliganded retinoblastoma protein pocket domain. Proteins (2011) 0.94

Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding. Mol Cell Biol (2012) 0.94

RB1: a prototype tumor suppressor and an enigma. Genes Dev (2016) 0.93

Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function. Genes Cancer (2012) 0.93

Regulation of the Chlamydomonas cell cycle by a stable, chromatin-associated retinoblastoma tumor suppressor complex. Plant Cell (2010) 0.91

Heterogenic final cell cycle by chicken retinal Lim1 horizontal progenitor cells leads to heteroploid cells with a remaining replicated genome. PLoS One (2013) 0.91

Physicochemical mechanisms of protein regulation by phosphorylation. Front Genet (2014) 0.87

Site-specific hyperphosphorylation of pRb in HIV-induced neurotoxicity. Mol Cell Neurosci (2011) 0.87

Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain. J Mol Biol (2013) 0.87

Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration. Cell Cycle (2016) 0.85

Structures and interaction analyses of integrin αMβ2 cytoplasmic tails. J Biol Chem (2011) 0.84

Structure, function, and tethering of DNA-binding domains in σ(54) transcriptional activators. Biopolymers (2013) 0.84

Structural mechanisms of DREAM complex assembly and regulation. Genes Dev (2015) 0.84

Cyclin-dependent kinase-mediated phosphorylation of RBP1 and pRb promotes their dissociation to mediate release of the SAP30·mSin3·HDAC transcriptional repressor complex. J Biol Chem (2010) 0.83

Novel roles of plant RETINOBLASTOMA-RELATED (RBR) protein in cell proliferation and asymmetric cell division. J Exp Bot (2013) 0.81

CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation. Oncogene (2015) 0.81

The Roles of MDM2 and MDMX Phosphorylation in Stress Signaling to p53. Genes Cancer (2012) 0.81

A comparative study of Whi5 and retinoblastoma proteins: from sequence and structure analysis to intracellular networks. Front Physiol (2014) 0.81

Retinoblastoma protein modulates the inverse relationship between cellular proliferation and elastogenesis. J Biol Chem (2011) 0.80

Phosphorylation puts the pRb tumor suppressor into shape. Genes Dev (2012) 0.79

Human herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes. Proc Natl Acad Sci U S A (2013) 0.79

(-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization. Mol Cell Oncol (2015) 0.78

Phosphorylation of the Retinoblastoma protein (Rb) on serine-807 is required for association with Bax. Cell Cycle (2014) 0.78

Binding to retinoblastoma pocket domain does not alter the inter-domain flexibility of the J domain of SV40 large T antigen. Arch Biochem Biophys (2011) 0.78

IGF-2 is necessary for retinoblastoma-mediated enhanced adaptation after small-bowel resection. J Gastrointest Surg (2014) 0.77

E2 superfamily of ubiquitin-conjugating enzymes: constitutively active or activated through phosphorylation in the catalytic cleft. Sci Rep (2015) 0.76

RRD-251 enhances All-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells. Oncotarget (2016) 0.76

PRMT4-mediated arginine methylation negatively regulates retinoblastoma tumor suppressor protein and promotes E2F-1 dissociation. Mol Cell Biol (2014) 0.76

The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7. Neoplasia (2012) 0.76

pRb controls estrogen receptor alpha protein stability and activity. Oncotarget (2013) 0.76

Novel retinoblastoma mutation abrogating the interaction to E2F2/3, but not E2F1, led to selective suppression of thyroid tumors. Cancer Sci (2014) 0.75

A Strategy for Direct Chemical Activation of the Retinoblastoma Protein. ACS Chem Biol (2016) 0.75

Multiple molecular interactions redundantly contribute to RB-mediated cell cycle control. Cell Div (2017) 0.75

Co-occurring protein phosphorylation are functionally associated. PLoS Comput Biol (2017) 0.75

Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins. J Biol Chem (2017) 0.75

Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family. J Mol Biol (2016) 0.75

Getting to S: CDK functions and targets on the path to cell-cycle commitment. F1000Res (2016) 0.75

CDKL1 promotes tumor proliferation and invasion in colorectal cancer. Onco Targets Ther (2017) 0.75

Phosphorylation of MAP65-1 by Arabidopsis Aurora kinases is required for efficient cell cycle progression. Plant Physiol (2016) 0.75

Articles cited by this

NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94

NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR (1994) 22.42

Cancer cell cycles. Science (1996) 21.29

The retinoblastoma protein and cell cycle control. Cell (1995) 20.21

The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62

Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell (1989) 6.68

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev (1992) 5.73

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell (1999) 4.94

Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson B (1995) 4.93

Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev (1992) 4.56

The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J (1996) 4.55

Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol (1998) 4.54

Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem (1997) 3.18

The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15

Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature (1998) 3.01

Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J (1991) 2.84

E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61

Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol (1997) 2.25

Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem (1996) 2.23

Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol (1993) 1.98

Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell (2005) 1.90

Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev (2002) 1.70

Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc Natl Acad Sci U S A (2003) 1.68

Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev (2000) 1.62

Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta (2001) 1.54

Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol Cell Biol (1999) 1.42

pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F. Oncogene (1998) 1.30

Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences. J Biol Chem (2005) 1.12

Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture. Mol Cell (2007) 1.09

Reverse mutational analysis reveals threonine-373 as a potentially sufficient phosphorylation site for inactivation of the retinoblastoma tumor suppressor protein (pRB). Cell Cycle (2006) 1.01

Purification and reconstitution of cyclin-dependent kinase 2 in four states of activity. Methods Enzymol (1997) 0.86

Transcriptional inhibition by the retinoblastoma protein. Philos Trans R Soc Lond B Biol Sci (1993) 0.80

Articles by these authors

Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol (2013) 2.58

Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell (2013) 2.49

Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase. Nature (2011) 1.86

Methylation of the retinoblastoma tumor suppressor by SMYD2. J Biol Chem (2010) 1.73

Identification of a DNA primase template tracking site redefines the geometry of primer synthesis. Nat Struct Mol Biol (2008) 1.42

A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases. J Mol Biol (2006) 1.39

Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev (2012) 1.37

The Rut pathway for pyrimidine degradation: novel chemistry and toxicity problems. J Bacteriol (2010) 1.26

Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1. Elife (2013) 1.22

Structure and regulatory mechanism of Aquifex aeolicus NtrC4: variability and evolution in bacterial transcriptional regulation. J Mol Biol (2008) 1.22

An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat Struct Mol Biol (2010) 1.20

Multisite phosphorylation networks as signal processors for Cdk1. Nat Struct Mol Biol (2013) 1.19

Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface. Structure (2013) 1.08

Distinguishing multiple chemotaxis Y protein conformations with laser-polarized 129Xe NMR. Protein Sci (2005) 1.03

A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression. Mol Cell (2013) 1.02

An N-terminal acidic region of Sgs1 interacts with Rpa70 and recruits Rad53 kinase to stalled forks. EMBO J (2012) 0.99

Cks confers specificity to phosphorylation-dependent CDK signaling pathways. Nat Struct Mol Biol (2013) 0.99

Structural basis of DNA recognition by the alternative sigma-factor, sigma54. J Mol Biol (2007) 0.99

Development of a functionalized xenon biosensor. J Am Chem Soc (2004) 0.98

Rif1 and Rif2 shape telomere function and architecture through multivalent Rap1 interactions. Cell (2013) 0.97

Crystal structure of the unliganded retinoblastoma protein pocket domain. Proteins (2011) 0.94

The C-terminal RpoN domain of sigma54 forms an unpredicted helix-turn-helix motif similar to domains of sigma70. J Biol Chem (2005) 0.93

Enzymatic production of 3,6-anhydro-L-galactose from agarose and its purification and in vitro skin whitening and anti-inflammatory activities. Appl Microbiol Biotechnol (2012) 0.90

Protein signal assignments using specific labeling and cell-free synthesis. J Biomol NMR (2004) 0.89

Applications of laser-polarized 129Xe to biomolecular assays. Magn Reson Imaging (2003) 0.87

1H nuclear magnetic resonance brain metabolomics in neonatal mice after hypoxia-ischemia distinguished normothermic recovery from mild hypothermia recoveries. Pediatr Res (2013) 0.87

Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex. J Biol Chem (2005) 0.85

Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolites. Int J Mol Sci (2011) 0.84

Structure, function, and tethering of DNA-binding domains in σ(54) transcriptional activators. Biopolymers (2013) 0.84

Structural studies of MJ1529, an O6-methylguanine-DNA methyltransferase. Magn Reson Chem (2006) 0.84

Design of a conformation-sensitive xenon-binding cavity in the ribose-binding protein. Angew Chem Int Ed Engl (2004) 0.82

SAS solution structures of the apo and Mg2+/BeF3(-)-bound receiver domain of DctD from Sinorhizobium meliloti. Biochemistry (2005) 0.82

Solution structure of a putative ribosome binding protein from Mycoplasma pneumoniae and comparison to a distant homolog. J Struct Funct Genomics (2003) 0.80

The novel catabolic pathway of 3,6-anhydro-L-galactose, the main component of red macroalgae, in a marine bacterium. Environ Microbiol (2014) 0.79

NMR structure of the N-terminal domain of the replication initiator protein DnaA. J Struct Funct Genomics (2007) 0.79

Selective chromium(VI) ligands identified using combinatorial peptoid libraries. J Am Chem Soc (2013) 0.78

13C NMR metabolomic evaluation of immediate and delayed mild hypothermia in cerebrocortical slices after oxygen-glucose deprivation. Anesthesiology (2013) 0.76

The structure of a monomeric mutant Cks protein reveals multiple functions for a conserved hinge-region proline. J Mol Biol (2011) 0.76